文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

体力表现与维生素D:老年黑人女性PODA随机临床试验

Physical Performance and Vitamin D in Elderly Black Women-The PODA Randomized Clinical Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

PODA试验纳入260名健康老年黑人女性,基线血清25(OH)D为53 nmol/L,随机分入安慰剂组或调整维生素D3剂量维持25(OH)D>75 nmol/L的活性组,随访3年每6个月评估握力、SPPB、10次起坐和6分钟步行距离。结果显示两组各项体力表现随时间的变化模式无实质差异,维持25(OH)D>75 nmol/L未能预防体力表现下降。

要点

  • 健康老年黑人女性维持25(OH)D>75 nmol/L对预防体力表现下降无获益。
  • 握力和6分钟步行距离随时间下降,SPPB随时间增加,两组间无实质差异。
  • 基线25(OH)D为53 nmol/L,260人入组,184人完成3年随访。

核心结论

  • 在健康老年黑人女性中,维持血清25(OH)D>75 nmol/L对预防体力表现下降没有获益。

研究设计与样本

  • PODA试验为前瞻性、随机、安慰剂对照、双模拟设计,两组之一为调整安慰剂维生素D3以维持血清25(OH)D>75 nmol/L。
  • 目标人群为血清25(OH)D在20至65 nmol/L之间的健康老年黑人女性,共260人入组,184人完成3年研究。
  • 研究持续3年,每6个月测量握力、简易体能状况量表(SPPB)、10次起坐和6分钟步行距离。
  • 平均年龄68.2岁,基线25(OH)D为53 nmol/L,基线总SPPB为11(10至12)。

主要发现

  • 握力和6分钟步行测试随时间下降,SPPB随时间增加。
  • 安慰剂组与活性维生素D3组在所有体力表现指标的时间变化模式上无实质差异。

临床怎么用

  • 对于健康老年黑人女性,不应仅以维持血清25(OH)D>75 nmol/L为目标来期望预防体力表现下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There is limited information on the influence of vitamin D on physical performance in black Americans. OBJECTIVE: To determine if maintenance of serum 25(OH)D >75 nmol/L prevents a decline in physical performance. DESIGN: The Physical Performance, Osteoporosis and Vitamin D in African American Women (PODA) trial had a prospective, randomized, placebo controlled, double-dummy design with two arms: one of which is placebo vitamin D3 adjusted to maintain serum 25(OH)D >75 nmol/L. PATIENTS: The target population was healthy elderly black women with serum 25(OH)D between 20 and 65 nmol/L. The trial was 3 years in duration with measurement of physical performance every 6 months: grip strength, Short Physical Performance Battery (SPPB), 10 chair rises, and 6-minute walk distance. A total of 260 women entered the study and 184 completed 3 years. Mean age was 68.2 years. Baseline 25(OH)D was 53 nmol/L; total SPPB was 11 (10 to 12). SETTING: Research center in an academic health center. MAIN OUTCOMES MEASURE: Prevention of decline in physical performance measures. INTERVENTION: Participants were randomly assigned to placebo or active vitamin D. Vitamin D3 dose was adjusted to maintain serum 25(OH)D >75 nmol/L. RESULTS: There was a decline with time in grip strength and the 6-minute walk test. The SPBB increased with time. There were no substantial differences between the placebo and active vitamin D3 groups with respect to the temporal patterns observed for any of the performance measures. CONCLUSION: There is no benefit of maintaining serum 25(OH)D >75 nmol/L in preventing the decline in physical performance in healthy black American women.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Aloia JF, Mikhail M, Fazzari M, et al. Physical Performance and Vitamin D in Elderly Black Women-The PODA Randomized Clinical Trial. J Clin Endocrinol Metab. 2019. PMID: 30496578. doi:10.1210/jc.2018-01418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。